About the study
Living with inherited cancer risk can bring questions about screening, prevention, and family conversations, as well as challenges related to uncertainty, healthcare decisions, and difficult emotions. Everyone's experience is different.
Previvors are people with a genetic predisposition to cancer who have not been diagnosed with cancer. You do not need to use that word for yourself to take part.
The PreCharge study, funded by the National Cancer Institute (Award Number R44CA275673), is testing a digital program designed to help people with hereditary cancer syndromes who have not been diagnosed with cancer strengthen their coping skills, build resilience, and stay engaged in their healthcare. The study is conducted by ProChange Behavior Solutions.
The PreCharge study is a six-month randomized controlled trial in which participants complete three online surveys, each taking about 10 minutes. Participants are randomly assigned to one of two groups. You will not be able to choose which group you are assigned to. One group receives access to the PreCharge digital program, including daily text messages and online activities and tools. Participants can spend as much or as little time as they want interacting with the program. The other group does not receive access to the program during the study. Comparing the groups will help researchers determine whether PreCharge improves coping, resilience, and healthcare engagement.
Participants can earn up to $180 in electronic gift cards for completing study surveys.